To support developing assays platform of drug screening and subunit vaccines of coronavirus, which will contribute to product innovation of COVID-19 pandemic control

Grant number: INV-006377

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $359,820
  • Funder

    Gates Foundation
  • Principal Investigator

    N/A

  • Research Location

    China
  • Lead Research Institution

    Institute of Microbiology, Chinese Academy of Sciences
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A

Publicationslinked via Europe PMC

Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines.

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant.